Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HIMA health care cost control proposals

This article was originally published in The Gray Sheet

Executive Summary

The Health Industry Manufacturers Association is developing proposals for alternatives to a freeze on technology/procedure reimbursement levels as a short-term solution to rising health care costs. Price freezes are one of several options reportedly under serious consideration by President Clinton's health reform task force. Within the next several weeks, HIMA plans to submit its proposals to task force operations chief Ira Magaziner, who asked HIMA to develop the document. HIMA's board plans to discuss the proposals during the association's annual meeting the week of March 28.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel